TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma - Teramachi, Jumpei; Tenshin, Hirofumi; Hiasa, Masahiro; Oda, Asuka; Bat-Erdene, Ariunzaya; Harada, Takeshi; Nakamura, Shingen; Ashtar, Mohannad; Shimizu, So; Iwasa, Masami; Sogabe, Kimiko; Oura, Masahiro; et al. (Haematologica (Roma), 2021)
Keywords: Animals; Bone Marrow Cells; MAP Kinase Kinase Kinases; Mice; Multiple Myeloma - drug therapy; NF-kappa B; Osteoclasts; Osteolysis; RANK Ligand - genetics; Tumor Microenvironment